80 related articles for article (PubMed ID: 20043126)
1. Long-term feeding of a synthetic diet rich in disaccharides induces hepatic fibrosis in nonalcoholic fatty liver disease in Zucker rats.
Fukunishi S; Nishio H; Fukuda A; Takeshita A; Hanafusa T; Higuchi K; Suzuki K
Int J Mol Med; 2010 Feb; 25(2):187-93. PubMed ID: 20043126
[TBL] [Abstract][Full Text] [Related]
2. Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats.
Shirouchi B; Nagao K; Inoue N; Furuya K; Koga S; Matsumoto H; Yanagita T
J Agric Food Chem; 2008 Apr; 56(7):2375-9. PubMed ID: 18324772
[TBL] [Abstract][Full Text] [Related]
3. A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats.
Gudbrandsen OA; Wergedahl H; Berge RK
Nutrition; 2009 May; 25(5):574-80. PubMed ID: 19101115
[TBL] [Abstract][Full Text] [Related]
4. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
Raju J; Bird RP
Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
[TBL] [Abstract][Full Text] [Related]
5. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
[TBL] [Abstract][Full Text] [Related]
7. Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats.
Noto A; Zahradka P; Ryz NR; Yurkova N; Xie X; Taylor CG
Metabolism; 2007 Jan; 56(1):142-51. PubMed ID: 17161237
[TBL] [Abstract][Full Text] [Related]
8. The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats.
Deng XQ; Chen LL; Li NX
Liver Int; 2007 Jun; 27(5):708-15. PubMed ID: 17498258
[TBL] [Abstract][Full Text] [Related]
9. [Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats].
Chen LL; Deng XQ; Li NX
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1434-7. PubMed ID: 17785073
[TBL] [Abstract][Full Text] [Related]
10. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
[TBL] [Abstract][Full Text] [Related]
11. Dietary single cell protein reduces fatty liver in obese Zucker rats.
Gudbrandsen OA; Wergedahl H; Liaset B; Espe M; Mørk S; Berge RK
Br J Nutr; 2008 Oct; 100(4):776-85. PubMed ID: 18346305
[TBL] [Abstract][Full Text] [Related]
12. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
13. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
Mine T; Miura K; Kajioka T; Kitahara Y
Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
[TBL] [Abstract][Full Text] [Related]
14. [Dynamic changes of plasma levels of prostacycline and thromboxane A2 and their correlation with the severity of hepatic injury in rats with nonalcoholic fatty liver disease].
Fan JG; Zheng XY; Tian LY; Qian Y; Ding XD; Xu ZJ
Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):681-3. PubMed ID: 15623379
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
16. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
17. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
18. [The expression and significance of osteopontin in the development of nonalcoholic fatty liver fibrosis in rats].
Liu P; Chen DF; Wang J; Ai ZL; Fan LL; Wang XM; Yan LL
Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):831-4. PubMed ID: 19032867
[TBL] [Abstract][Full Text] [Related]
19. Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats.
Nagao K; Inoue N; Wang YM; Shirouchi B; Yanagita T
J Nutr; 2005 Jan; 135(1):9-13. PubMed ID: 15623825
[TBL] [Abstract][Full Text] [Related]
20. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes.
Kreuz S; Schoelch C; Thomas L; Rist W; Rippmann JF; Neubauer H
Diabetes Metab Res Rev; 2009 Sep; 25(6):577-86. PubMed ID: 19618481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
